サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427678

依存症治療の世界市場レポート 2024

Addictions Therapeutics Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
依存症治療の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

依存症治療の市場規模は、今後数年間で大幅な成長が見込まれています。2028年には6.0%の年間複合成長率（CAGR）で88億3,000万米ドルに成長すると予想されます。予測期間で予想される成長は、薬物啓発キャンペーンの急増、合成薬物や新しい精神活性物質の出現、ライフスタイルの変化とストレス要因の増加、リハビリ施設の拡大、依存症治療における遠隔医療サービスの統合など、さまざまな要因に起因する可能性があります。予測期間中に予想される主な動向には、診断における技術進歩、神経科学の進歩、依存症問題に対処するための製薬会社と他の利害関係者のパートナーシップと協力、依存症治療のための革新的な医薬品の発売などが含まれます。これらの動向は総合的に、依存症治療のアプローチと解決策の進化と改善に貢献しています。

予測されるアルコール消費量の増加は、依存症治療市場の成長を推進する重要な促進力となっています。アルコール消費にはエチルアルコールを含む飲料の摂取が伴いますが、依存症治療は、その抑うつ効果を緩和し、神経伝達物質間のバランスを回復することによって、アルコール関連依存症に対処することを目的としています。これらの治療は、アルコールへの渇望を減らし、不眠症、不安、落ち着きのなさなどの離脱症状を軽減するのに役立ち、それによってアルコール摂取量の減少を促進します。特に、2023年2月のカナダ統計局の報告書では、小売店や酒類当局での酒類売上高が注目すべき急増を示し、2022年3月31日までの会計年度では前年比2.4%増の261億米ドルに達したことが明らかになりました。ワインの売上も2.1%増加し、同期間に81億米ドルに達しました。2021年から2022年のアルコール類総販売額に占めるビールの割合は34.9％、次いでワインが31.3％、スピリッツが25.8％、サイダーとクーラーが8.0％となりました。その結果、アルコール消費量の増加により、依存症治療の需要が高まっています。

世界的にヘルスケア費が急増しているため、依存症治療市場の拡大が促進される傾向にあります。ヘルスケア支出には、特定の期間にわたって医療関連の商品やサービスに向けられた財源が含まれており、依存症治療の成長に大きく貢献しています。ヘルスケア費の増加は、治療へのアクセスの向上を促進し、研究開発の取り組みを支援し、革新的な治療法の採用を促進し、物質使用障害に対する包括的なヘルスケアサービスを強化します。2022年3月にメディケア・メディケイド・サービスセンターが発表した2021年から2030年の国民医療支出（NHE）報告書に示されているように、予測される成長率は、2021年から2030年にかけて国民医療支出が年平均5.1%増加し、最高額は6兆8,000億米ドル近くになることを示しています。特に、メディケア支出は年間7.2%増加すると予想されており、メディケイド支出は2021年から2030年にかけて年率5.6%で増加すると予想されています。このヘルスケア支出の急増は、依存症治療市場の拡大を推進する促進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の依存症治療市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の依存症治療の市場規模実績と成長、2018年～2023年
  • 世界の依存症治療の市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の依存症治療市場、薬剤タイプ別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • ブプレノルフィン
  • ナルトレキソン
  • ブプロピオン
  • ジスルフィラム
  • ニコチン代替製品
  • バレニクリン
  • その他の薬物
  • 世界の依存症治療市場、治療タイプ別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • オピオイド依存症治療
  • アルコール依存症治療
  • ニコチン依存症治療
  • その他の薬物依存症治療
  • 世界の依存症治療市場、治療センター別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 入院治療センター
  • 居住型治療センター
  • 外来治療センター
  • 世界の依存症治療市場、流通チャネル別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 病院薬局
  • 医療店
  • その他の流通チャネル
  • 世界の依存症治療市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 公共
  • 個人
  • 政府

第7章 地域と国の分析

  • 世界の依存症治療市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界の依存症治療市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 依存症治療市場の競合情勢
  • 依存症治療市場の企業プロファイル
    • Pfizer Inc.
    • Novartis AG
    • GlaxoSmithKline plc
    • Gilead Sciences Inc.
    • Novo Nordisk A/S

第31章 その他の大手と革新的な企業

  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Bausch Health Companies Inc.
  • Sun Pharmaceutical Industries Limited
  • Perrigo Company plc
  • Purdue Pharma LP
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Inc.
  • Hikma Pharmaceuticals plc
  • Amneal Pharmaceuticals Inc.
  • Mallinckrodt Plc
  • Alkermes plc.
  • Glenmark Pharmaceuticals Limited
  • Indivior plc.
  • Lannett Company Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13522

Addiction therapeutics encompasses the medications, treatments, and management strategies designed to address various forms of addiction, assisting individuals in overcoming substance use disorders (SUDs) and other addictive behaviors. The approach involves a combination of medications and therapeutic interventions, including group and individual therapy sessions, aimed at preventing substance misuse and supporting recovery.

Key addiction therapeutics include medications such as buprenorphine, naltrexone, bupropion, disulfiram, nicotine replacement products, varenicline, and others. For instance, buprenorphine is a semi-synthetic narcotic analgesic used to mimic the effects of opioid medicines, helping to prevent withdrawal symptoms when an individual discontinues opioid use. Different types of addiction therapeutics cater to specific substance dependencies, including opioid addiction treatment, alcohol addiction treatment, nicotine addiction treatment, and treatments for other substance addictions. These therapeutic interventions can be implemented in various treatment centers, including inpatient treatment centers, residential treatment centers, and outpatient treatment centers. Distribution channels for addiction therapeutics encompass hospital pharmacies, medical stores, and others. These therapeutic solutions are accessible through public, private, and government healthcare settings, contributing to comprehensive and widespread addiction treatment and recovery efforts.

The addictions therapeutics market research report is one of a series of new reports from The Business Research Company that provides addictions therapeutics market statistics, including addictions therapeutics industry global market size, regional shares, competitors with a addictions therapeutics market share, detailed addictions therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the addictions therapeutics industry. This addictions therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The addictions therapeutics market size has grown strongly in recent years. It will grow from $6.56 billion in 2023 to $7.01 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth observed in the historical period can be attributed to several factors, including the increased use of addictive substances such as alcohol, tobacco, and drugs, a growing awareness and prevalence of substance abuse disorders, the legalization of marijuana in various states, and increased funding and support for addiction treatment initiatives. These elements collectively contributed to the expansion of efforts and resources dedicated to addressing addiction-related challenges and promoting treatment and recovery.

The addictions therapeutics market size is expected to see strong growth in the next few years. It will grow to $8.83 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The anticipated growth in the forecast period can be attributed to various factors, including the proliferation of drug awareness campaigns, the emergence of synthetic drugs and new psychoactive substances, changing lifestyles and increased stress factors, the expansion of rehabilitation facilities, and the integration of telehealth services in addiction treatment. Key trends expected in the forecast period encompass technological advancements in diagnostics, neuroscientific advances, partnerships and collaborations between pharmaceutical companies and other stakeholders to address addiction issues, and the launch of innovative drugs for addiction therapeutics. These trends collectively contribute to the evolution and improvement of addiction treatment approaches and solutions.

The projected rise in alcohol consumption stands as a significant driver propelling the growth of the addiction therapeutics market. Alcohol consumption entails the intake of beverages containing ethyl alcohol, and addiction therapeutics aim to address alcohol-related addiction by moderating its depressive effects and reinstating the balance between neurotransmitters. These therapeutics help reduce alcohol cravings, alleviate withdrawal symptoms such as insomnia, anxiety, and restlessness, thereby encouraging reduced alcohol consumption. Notably, a report by Statistics Canada in February 2023 revealed a noteworthy surge in alcoholic beverage sales at retail outlets and liquor authorities, reaching $26.1 billion for the fiscal year ending March 31, 2022-an increase of 2.4% from the previous year. Wine sales also experienced a 2.1% uptick, reaching $8.1 billion in the same period. Beer constituted 34.9% of total alcohol sales value in 2021-2022, followed by wine at 31.3%, spirits at 25.8%, and ciders and coolers at 8.0%. Consequently, the escalating alcohol consumption is fueling the demand for addiction therapeutics.

The burgeoning healthcare expenditure globally is poised to foster the expansion of the addiction therapeutics market. Healthcare expenditure encompasses the financial resources directed towards healthcare-related goods and services over a specific period, contributing significantly to the growth of addiction therapeutics. Increased healthcare expenditure facilitates improved treatment accessibility, supports research and development initiatives, promotes the adoption of innovative therapies, and enhances comprehensive healthcare services for substance use disorders. As illustrated by the 2021-2030 National Health Expenditure (NHE) report from the Centers for Medicare & Medicaid Services in March 2022, the projected growth indicates an average annual increase of 5.1% in national health spending between 2021 and 2030, culminating in nearly $6.8 trillion. Notably, Medicare spending is expected to rise by 7.2% annually, while Medicaid spending will grow at a 5.6% annual rate from 2021 to 2030. This upsurge in healthcare expenditure serves as a driving force propelling the expansion of the addiction therapeutics market.

Prominent players within the addiction therapeutics market are actively pioneering innovative solutions, particularly drugs aimed at addressing cocaine use disorders (CUD), to cater to broader customer bases, amplify sales, and augment revenue streams. Drugs developed for CUD are specifically crafted medications intended to assist individuals grappling with cocaine addiction or dependence. An exemplar in this domain unfolded in January 2023 when Tempero Bio, a US-based biopharmaceutical firm, revealed the FDA's approval for TMP-301, its investigational candidate. This distinct product distinguishes itself as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM), uniquely tailored to combat CUD. TMP-301's standout characteristics lie in its potency, selectivity, and oral availability, aimed at effectively curbing the hyperactive glutamate signaling associated with CUD.

Key industry players within the addiction therapeutics sector are strategically embracing partnerships to tackle nicotine addiction through smartphone interventions. Strategic partnerships denote collaborative endeavors wherein companies synergize their strengths and resources for mutual advantages and success. For instance, in January 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology giant, entered into a partnership with Alex Therapeutics, a Sweden-based entity specializing in digital therapeutics. The primary focus of this collaboration revolves around a digital therapeutic designed to combat nicotine addiction via smartphone intervention. Developed by Alex Therapeutics in alignment with the specifications of the German healthcare system alongside Pfizer Germany, the medical device represents the crux of this partnership. Leveraging Alex Therapeutics' AI-powered digital therapeutics platform, the Alex DTx Platform, this collaboration integrates evidence-based psychological approaches, notably Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), with artificial intelligence. The platform offers personalized standalone treatments, aiming to address unmet needs among patients on a global scale. This strategic alliance signifies a concerted effort to revolutionize addiction therapeutics using digital interventions, potentially reshaping nicotine addiction treatments.

In March 2023, Indivior, a US-based pharmaceutical company, completed the acquisition of Opiant Pharmaceuticals Inc for an estimated $145 million. This strategic move is intended to enhance Indivior's portfolio in investigational opioid overdose therapy, fortify its scientific research capabilities, and further expand its offerings in the field of addiction treatment. Opiant Pharmaceuticals Inc., a US-based biopharmaceutical company specializing in medicines for addiction and drug overdose.

Major companies operating in the addictions therapeutics market report are Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Gilead Sciences Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Insys Therapeutics Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Alchem International Ltd, Avalo Therapeutics Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

North America was the largest region in the addictions therapeutics market in 2023. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the addictions therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The addiction therapeutics market consists of revenues earned by entities by providing cognitive behavioral therapy, contingency management for addiction, rational emotive behavior therapy (REBT), motivational interviewing, family therapy for addiction, facilitation therapy for addiction, eye movement desensitization and reprocessing (EMDR), dialectical behavior therapy, matrix model for addiction and person-centered therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The addiction therapeutics market also includes sales of suboxone, methadone, naltrexone, antidepressants, and acamprosate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Addictions Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on addictions therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for addictions therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The addictions therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Drug Type: Buprenorphine; Naltrexone; Bupropion; Disulfiram; Nicotine Replacement Products; Varenicline; Other Drugs
  • 2) By Treatment Type: Opioid Addiction Treatment; Alcohol Addiction Treatment; Nicotine Addiction Treatment; Other Substance Addiction Treatment
  • 3) By Treatment Center: Inpatient Treatment Center; Residential Treatment Center; Outpatient Treatment Center
  • 4) By Distribution Channel: Hospital Pharmacies; Medical Stores; Other Distribution Channel
  • 5) By Application: Public; Private; Government
  • Companies Mentioned: Pfizer Inc.; Novartis AG; GlaxoSmithKline plc; Gilead Sciences Inc.; Novo Nordisk A/S
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Addictions Therapeutics Market Characteristics

3. Addictions Therapeutics Market Trends And Strategies

4. Addictions Therapeutics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Addictions Therapeutics Market Size and Growth

  • 5.1. Global Addictions Therapeutics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Addictions Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Addictions Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Addictions Therapeutics Market Segmentation

  • 6.1. Global Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Buprenorphine
  • Naltrexone
  • Bupropion
  • Disulfiram
  • Nicotine Replacement Products
  • Varenicline
  • Other Drugs
  • 6.2. Global Addictions Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Opioid Addiction Treatment
  • Alcohol Addiction Treatment
  • Nicotine Addiction Treatment
  • Other Substance Addiction Treatment
  • 6.3. Global Addictions Therapeutics Market, Segmentation By Treatment Center, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inpatient Treatment Center
  • Residential Treatment Center
  • Outpatient Treatment Center
  • 6.4. Global Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Medical Stores
  • Other Distribution Channel
  • 6.5. Global Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Public
  • Private
  • Government

7. Addictions Therapeutics Market Regional And Country Analysis

  • 7.1. Global Addictions Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Addictions Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Addictions Therapeutics Market

  • 8.1. Asia-Pacific Addictions Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Addictions Therapeutics Market

  • 9.1. China Addictions Therapeutics Market Overview
  • 9.2. China Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Addictions Therapeutics Market

  • 10.1. India Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Addictions Therapeutics Market

  • 11.1. Japan Addictions Therapeutics Market Overview
  • 11.2. Japan Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Addictions Therapeutics Market

  • 12.1. Australia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Addictions Therapeutics Market

  • 13.1. Indonesia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Addictions Therapeutics Market

  • 14.1. South Korea Addictions Therapeutics Market Overview
  • 14.2. South Korea Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Addictions Therapeutics Market

  • 15.1. Western Europe Addictions Therapeutics Market Overview
  • 15.2. Western Europe Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Addictions Therapeutics Market

  • 16.1. UK Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Addictions Therapeutics Market

  • 17.1. Germany Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Addictions Therapeutics Market

  • 18.1. France Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Addictions Therapeutics Market

  • 19.1. Italy Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Addictions Therapeutics Market

  • 20.1. Spain Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Addictions Therapeutics Market

  • 21.1. Eastern Europe Addictions Therapeutics Market Overview
  • 21.2. Eastern Europe Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Addictions Therapeutics Market

  • 22.1. Russia Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Addictions Therapeutics Market

  • 23.1. North America Addictions Therapeutics Market Overview
  • 23.2. North America Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Addictions Therapeutics Market

  • 24.1. USA Addictions Therapeutics Market Overview
  • 24.2. USA Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Addictions Therapeutics Market

  • 25.1. Canada Addictions Therapeutics Market Overview
  • 25.2. Canada Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Addictions Therapeutics Market

  • 26.1. South America Addictions Therapeutics Market Overview
  • 26.2. South America Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Addictions Therapeutics Market

  • 27.1. Brazil Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Addictions Therapeutics Market

  • 28.1. Middle East Addictions Therapeutics Market Overview
  • 28.2. Middle East Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Addictions Therapeutics Market

  • 29.1. Africa Addictions Therapeutics Market Overview
  • 29.2. Africa Addictions Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Addictions Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Addictions Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Addictions Therapeutics Market Competitive Landscape And Company Profiles

  • 30.1. Addictions Therapeutics Market Competitive Landscape
  • 30.2. Addictions Therapeutics Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. GlaxoSmithKline plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Gilead Sciences Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novo Nordisk A/S
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Addictions Therapeutics Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. Mylan N.V.
  • 31.3. Bausch Health Companies Inc.
  • 31.4. Sun Pharmaceutical Industries Limited
  • 31.5. Perrigo Company plc
  • 31.6. Purdue Pharma L.P.
  • 31.7. Dr. Reddy's Laboratories Ltd.
  • 31.8. Cipla Inc.
  • 31.9. Hikma Pharmaceuticals plc
  • 31.10. Amneal Pharmaceuticals Inc.
  • 31.11. Mallinckrodt Plc
  • 31.12. Alkermes plc.
  • 31.13. Glenmark Pharmaceuticals Limited
  • 31.14. Indivior plc.
  • 31.15. Lannett Company Inc.

32. Global Addictions Therapeutics Market Competitive Benchmarking

33. Global Addictions Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Addictions Therapeutics Market

35. Addictions Therapeutics Market Future Outlook and Potential Analysis

  • 35.1 Addictions Therapeutics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Addictions Therapeutics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Addictions Therapeutics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer